by Mrinalini Nayak | Oct 3, 2023
Nvidia announced three back-to-back enterprise deals with Indian conglomerates in September, deepening its commitment to the growing AI ecosystem in the South Asian Nation. The chipmaker will partner with Reliance Industries, Tata Group and Infosys to build an AI...
by Gerard Edic | Oct 1, 2023
Rivian’s boss isn’t afraid of the potential release of Tesla’s Cybertruck, a long-pledged electric truck that boasts a higher number of reservation requests than Rivian has cars on the road. That’s because R.J. Scaringe doesn’t see the product from the...
by Mariam Kiparoidze | Sep 28, 2023
Even though Covid-19 cases and hospitalization numbers are up, they won’t be a shot in the arm for either Moderna or Pfizer stock. Pfizer (NYSE:PFE) closed at $32.69 per share, down by 36.2% year to date on September 22. Moderna (Nasdaq:MRNA) ended the week on a...
by James Van Bramer | Sep 22, 2023
A strike may have halted movie and film television production, but investors are staging their own walkout on the stocks of streaming companies. Netflix, which has handsomely outperformed the market this year, fell 9% through the first three weeks of September. Roku...
by Trina Mannino | Dec 2, 2022
When venture capitalist Sheel Mohnot went to book an accommodation on Airbnb recently, he found that the additional fees he was required to pay tallied up to nearly the same amount as the actual booking rate. He made his displeasure known in a tweet. Disgruntled...
by Randi Love | Nov 28, 2022
Antidepressant drugs have been on the market since the 1950s, but Axsome Therapeutics is betting its new treatment will have a major impact on patients and doctors. In late October, the company launched Auvelity, a prescription-only, fast-acting, oral medication aimed...